<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cc2-leuk" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cc2-leuk</book-part-id>
      <title-group>
        <title><italic toggle="yes">CLCN2</italic>-Related Leukoencephalopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>van der Knaap</surname>
            <given-names>Marjo S</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Child Neurology and Neuroscience Campus Amsterdam<break/>VU University Medical Center<break/>Amsterdam, Netherlands</aff>
          <email>ms.vanderknaap@vumc.nl</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Depienne</surname>
            <given-names>Christel</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>INSERM, U1127&#x02013;ICM<break/>H&#x000f4;pital Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re<break/>Paris, France</aff>
          <email>christel.depienne@upmc.fr</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sedel</surname>
            <given-names>Frederic</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>MedDay Pharmaceuticals<break/>ICM-Brain and Spine Institute-IPEPs<break/>Groupe Hospitalier Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re<break/>Paris, France</aff>
          <email>frederic.sedel@medday-pharma.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Abbink</surname>
            <given-names>Truus EM</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Department of Child Neurology and Neuroscience Amsterdam<break/>VU University Medical Center<break/>Amsterdam, Netherlands</aff>
          <email>g.abbink@vumc.nl</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>5</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="cd-chst3" document-type="chapter"><italic toggle="yes">CHST3</italic>-Related Skeletal Dysplasia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="clcn7" document-type="chapter"><italic toggle="yes">CLCN7</italic>-Related Osteopetrosis</related-object>
      <abstract id="cc2-leuk.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">CLCN2</italic>-related leukoencephalopathy (CC2L) is characterized by nonspecific neurologic findings, mild visual impairment from chorioretinopathy or optic atrophy, male infertility, and characteristic findings on brain MRI. Neurologic findings include mild ataxia (action tremor and gait instability following initially normal motor development; occasionally mild spasticity), learning disabilities in some (ranging from mild to severe cognitive impairment), and headaches in some (usually intermittent, severe, and diffuse). Affected individuals remain ambulatory and do not require support for walking, and none has become blind. To date CC2L has been reported or identified in 16 individuals from 15 families. It is not yet known if the findings occurring in single individuals (i.e., vertigo, tinnitus, and progressive hearing loss; psychiatric symptoms; and paroxysmal kinesigenic dyskinesia) are part of the phenotypic spectrum or unrelated findings.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of CC2L is established in a proband by identification of biallelic pathogenic variants in <italic toggle="yes">CLCN2</italic> on molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Supportive care including physical therapy and rehabilitation to improve motor function, special education as needed, treatment of headache, guidance for visual impairment.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual: neurologic examination, ophthalmologic examination, and audiologic assessment</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Presymptomatic diagnosis and treatment is warranted in older and younger sibs of a proband to identify those who would benefit from early diagnosis and routine surveillance for motor, cognitive, vision, and hearing impairment.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>CC2L is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible when the <italic toggle="yes">CLCN2</italic> pathogenic variants in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cc2-leuk.Diagnosis">
        <title>Diagnosis</title>
        <sec id="cc2-leuk.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">CLCN2</italic>-related leukoencephalopathy (CC2L) <bold>should be suspected</bold> in individuals with certain nonspecific neurologic findings, decreased visual acuity, and characteristic abnormalities on brain MRI [<xref ref-type="bibr" rid="cc2-leuk.REF.depienne.2013.659">Depienne et al 2013</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.di_bella.2014.1217">Di Bella et al 2014</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.hanagasi.2015.544">Hanagasi et al 2015</xref>].</p>
          <sec id="cc2-leuk.Neurologic">
            <title>Neurologic</title>
            <list list-type="bullet">
              <list-item>
                <p>Mild ataxia</p>
              </list-item>
              <list-item>
                <p>Learning disabilities</p>
              </list-item>
              <list-item>
                <p>Headache</p>
              </list-item>
            </list>
          </sec>
          <sec id="cc2-leuk.Visual">
            <title>Visual</title>
            <list list-type="bullet">
              <list-item>
                <p>Decreased vision caused by chorioretinopathy or optic atrophy</p>
              </list-item>
            </list>
          </sec>
          <sec id="cc2-leuk.Brain_MRI">
            <title>Brain MRI</title>
            <p><bold>Major criteria.</bold> Abnormally low signal on T<sub>1</sub>-weighted images and abnormally high signal on T<sub>2</sub>-weighted images (<xref ref-type="fig" rid="cc2-leuk.F1">Figure 1</xref>) in the:</p>
            <list list-type="bullet">
              <list-item>
                <p>Posterior limbs of the internal capsules</p>
              </list-item>
              <list-item>
                <p>Midbrain cerebral peduncles</p>
              </list-item>
              <list-item>
                <p>Middle cerebellar peduncles</p>
              </list-item>
            </list>
            <p>
              <bold>Supportive criteria</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Abnormally low signal on T<sub>1</sub>-weighted images and abnormally high signal on T<sub>2</sub>-weighted images in the:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Pyramidal tracts in the pons</p>
                  </list-item>
                  <list-item>
                    <p>Central tegmental tracts in medulla, pons and midbrain</p>
                  </list-item>
                  <list-item>
                    <p>Superior cerebellar peduncles</p>
                  </list-item>
                  <list-item>
                    <p>Decussation of the superior cerebellar peduncles in the midbrain</p>
                  </list-item>
                  <list-item>
                    <p>Cerebellar white matter</p>
                  </list-item>
                  <list-item>
                    <p>Corpus callosum</p>
                  </list-item>
                  <list-item>
                    <p>Cerebral white matter, either with a signal behavior suggestive of hypomyelination<sup>*</sup> or nonspecific, mild inhomogeneous signal abnormalities.</p>
                  </list-item>
                </list>
                <p>* Mild T<sub>2</sub>-weighted hyperintensity of the white matter and mild T<sub>1</sub>-weighted hypointensity, isointensity, or hyperintensity relative to gray matter [<xref ref-type="bibr" rid="cc2-leuk.REF.schiffmann.2009.750">Schiffmann &#x00026; van der Knaap 2009</xref>]</p>
              </list-item>
              <list-item>
                <p>Diffusion restriction (assessed by apparent diffusion coefficient values [<xref ref-type="bibr" rid="cc2-leuk.REF.depienne.2013.659">Depienne et al 2013</xref>]) in part or all of the structures mentioned under major and supportive criteria.</p>
                <p>Note: More recently an affected individual had no diffusion restriction [<xref ref-type="bibr" rid="cc2-leuk.REF.di_bella.2014.1217">Di Bella et al 2014</xref>].</p>
              </list-item>
            </list>
          </sec>
          <sec id="cc2-leuk.Other">
            <title>Other</title>
            <list list-type="bullet">
              <list-item>
                <p><bold>Male infertility</bold> caused by oligospermia/azoospermia</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="cc2-leuk.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of CC2L <bold>is established</bold> in a proband by identification of biallelic pathogenic variants in <italic toggle="yes">CLCN2</italic> (see <xref ref-type="table" rid="cc2-leuk.T.molecular_genetic_testing_use">Table 1</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">CLCN2</italic> is performed first followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">CLCN2</italic> and other genes of interest (see <xref ref-type="sec" rid="cc2-leuk.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and sensitivity of multi-gene panels vary by laboratory and over time.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of chloride channel-2 related leukoencephalopathy.</p>
              <p>For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="cc2-leuk.T.molecular_genetic_testing_use" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Chloride Channel-2 Related Leukoencephalopathy</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">CLCN2</italic>
                  </td>
                  <td headers="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">All <italic toggle="yes">CLCN2</italic> pathogenic variants reported to date</td>
                </tr>
                <tr>
                  <td headers="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>5</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="cc2-leuk.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="cc2-leuk" object-id="cc2-leuk.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="cc2-leuk.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="cc2-leuk.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="cc2-leuk.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="cc2-leuk.TF.1.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="cc2-leuk.TF.1.5">
                <label>5. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="cc2-leuk.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="cc2-leuk.Clinical_Description">
          <title>Clinical Description</title>
          <p>Since its discovery in 2013, <italic toggle="yes">CLCN2</italic>-related leukoencephalopathy (CC2L) has been reported in eight individuals [<xref ref-type="bibr" rid="cc2-leuk.REF.depienne.2013.659">Depienne et al 2013</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.di_bella.2014.1217">Di Bella et al 2014</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.hanagasi.2015.544">Hanagasi et al 2015</xref>] and diagnosed in eight additional individuals from seven families [Author, personal observation]. Consequently, the phenotypic spectrum may only be partially known and statements about relative frequency of features are of limited value.</p>
          <p>The phenotypic spectrum of CC2L ranges from childhood onset with mild ataxia, learning disabilities, and headaches to adult onset with mild ataxia and decreased vision. Infertility has been observed in two adult males [<xref ref-type="bibr" rid="cc2-leuk.REF.di_bella.2014.1217">Di Bella et al 2014</xref>; Author, personal observation]. To date, single individuals with vertigo, tinnitus, and progressive hearing loss [<xref ref-type="bibr" rid="cc2-leuk.REF.depienne.2013.659">Depienne et al 2013</xref>]; psychiatric symptoms [<xref ref-type="bibr" rid="cc2-leuk.REF.depienne.2013.659">Depienne et al 2013</xref>]; and paroxysmal kinesigenic dyskinesia [<xref ref-type="bibr" rid="cc2-leuk.REF.hanagasi.2015.544">Hanagasi et al 2015</xref>] have been reported. Thus, it is not yet clear if these findings are part of the phenotype or unrelated findings.</p>
          <p>The disease course has been reported as stable to slowly progressive; considering that adults were previously normal, extremely slow progression is most likely. All individuals reported to date have remained ambulatory. The oldest known individual with CC2L is age 65 years. No disease-related deaths have been reported to date.</p>
          <p><bold>Motor skills.</bold> Initial motor development is normal. At presentation, most affected individuals display signs of mild cerebellar ataxia with action tremor and gait instability; some also show mild signs of spasticity.</p>
          <p>Affected individuals remain ambulatory and do not require support for walking.</p>
          <p><bold>Cognitive skills.</bold> Some have mild learning problems from early on, but most have normal intellect. One affected individual had severe cognitive impairment and psychosis.</p>
          <p><bold>Headache.</bold> Some affected individuals complain of intermittent severe diffuse headaches [Author, personal observation].</p>
          <p><bold>Eyes.</bold> Some affected individuals have a retinopathy or optic atrophy leading to mild visual impairment. Some affected individuals have visual field defects at formal testing, indicating subclinical retinopathy. None has become blind.</p>
          <p><bold>Male infertility.</bold> One male with azoospermia (but no neurologic dysfunction) was found to have CC2L during a work-up for infertility [<xref ref-type="bibr" rid="cc2-leuk.REF.di_bella.2014.1217">Di Bella et al 2014</xref>]. One male with a history of infertility was diagnosed with CC2L when he was investigated for severe headaches [Author, personal observation].</p>
          <p><bold>Routine laboratory tests,</bold> including CSF analysis, are normal.</p>
        </sec>
        <sec id="cc2-leuk.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Individuals with two null alleles and individuals with two missense pathogenic variants have been reported with onset in either childhood or adulthood without evidence of any genotype-phenotype correlations, although it should be noted that to date the number of affected individuals reported and known to the authors is small.</p>
        </sec>
        <sec id="cc2-leuk.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of CC2L is unknown. The small number of known affected individuals suggests that the disease is exceedingly rare. Numerous individuals with CC2L, however, may also remain undiagnosed because they remain asymptomatic at an advanced age, lack a specific clinical phenotype, or have findings (e.g., headaches or infertility due to azoospermia or oligozoospermia) that do not prompt evaluation by brain MRI.</p>
        </sec>
      </sec>
      <sec id="cc2-leuk.Genetically_Related_Allelic_Dis">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Although heterozygous <italic toggle="yes">CLCN2</italic> pathogenic variants have been reported as a cause of idiopathic generalized epilepsies, including childhood absence epilepsy, juvenile myoclonic epilepsy, and epilepsy with grand mal seizures on awakening [<xref ref-type="bibr" rid="cc2-leuk.REF.haug.2003.527">Haug et al 2003</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.d_agostino.2004.1500">D&#x02019;Agostino et al 2004</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.stogmann.2006.265">Stogmann et al 2006</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.everett.2007.145">Everett et al 2007</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.combi.2009.89">Combi et al 2009</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.kleefusslie.2009.954">Kleefuss-Lie at al 2009</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.saintmartin.2009.397">Saint-Martin et al 2009</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.klassen.2011.1036">Klassen et al 2011</xref>], these findings remain controversial. The original paper supporting these results was retracted [<xref ref-type="bibr" rid="cc2-leuk.REF.haug.2009.1043">Haug et al 2009</xref>]; although the authors still believed that mutation of <italic toggle="yes">CLCN2</italic> may contribute to epilepsy in some cases [<xref ref-type="bibr" rid="cc2-leuk.REF.haug.2009.1043">Haug et al 2009</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.kleefusslie.2009.954">Kleefuss-Lie at al 2009</xref>], functional studies of the <italic toggle="yes">CLCN2</italic> variants identified in individuals with epilepsy did not confirm their pathogenicity. Furthermore, similar variants were observed in individuals who did not have epilepsy [<xref ref-type="bibr" rid="cc2-leuk.REF.planellscases.2009">Planells-Cases &#x00026; Jentsch 2009</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.niemeyer.2010.3">Niemeyer at al 2010</xref>].</p>
        <p>The observations in chloride channel-2 related leukoencephalopathy do not support the hypothesis that loss-of-function <italic toggle="yes">CLCN2</italic> pathogenic variants confer an increased risk of epilepsy: No affected individuals with biallelic (homozygous or compound heterozygous) <italic toggle="yes">CLCN2</italic> pathogenic variants had epilepsy or a family history of epilepsy, indicating that partial or complete loss of chloride channel-2 function is insufficient per se to cause epilepsy.</p>
      </sec>
      <sec id="cc2-leuk.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Because the clinical findings of <italic toggle="yes">CLCN2</italic>-related leukoencephalopathy (CC2L) are nonspecific, it is not possible to establish the diagnosis on a clinical basis alone or to develop a differential diagnosis.</p>
        <p>In contrast, the differential diagnosis of the MRI findings of bilateral symmetric signal abnormalities of the middle cerebellar peduncles and variable signal abnormalities in the brain stem and cerebellar and cerebral white matter include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="lad-ad" document-type="chapter">Adult autosomal dominant leukoencephalopathy related to <italic toggle="yes">LMNB1</italic> duplications</related-object> is characterized by executive dysfunction, memory decline, personality changes, motor impairments, and seizures. Mean age of onset is in the fourth decade. Affected individuals eventually become bedridden with spasticity and rigidity. Brain MRI is characterized by cerebral white matter abnormalities with frontal preponderance.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="fragilex" document-type="chapter">Fragile X-associated tremor/ataxia syndrome</related-object>, which occurs in adult males (and some females) who have an <italic toggle="yes">FMR1</italic> premutation, is characterized by late-adult onset progressive cerebellar ataxia and intention tremor. Brain MRI shares with CC2L the typical middle cerebellar peduncle signal abnormalities, but lacks both the signal abnormalities in the cerebral peduncles and posterior limbs of the internal capsules and the diffusion restriction typical of CC2L.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="wilson" document-type="chapter">Wilson disease</related-object> is a disorder of copper metabolism that can present with hepatic, neurologic, or psychiatric disturbances, or a combination of these, in individuals ranging from age three years to older than 50 years. Kayser-Fleischer rings resulting from copper deposition in Descemet&#x02019;s membrane of the cornea are frequently present. Abnormalities of brain MRI are highly variable and may involve the brain stem, but with a configuration different from that of CC2L.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="alexander" document-type="chapter">Adult-onset Alexander disease</related-object> mainly affects the lower brain stem, which is clinically evident as bulbar dysfunction. The hallmark brain MRI abnormality is atrophy of the medulla oblongata. Brain stem signal abnormalities with a predilection for the medulla may also be present.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="x-ald" document-type="chapter">Adrenomyeloneuropathy</related-object> manifests most commonly in the late twenties with progressive paraparesis, sphincter disturbances, sexual dysfunction, and often impaired adrenocortical function. All features are progressive over decades. The primary MRI finding is spinal cord atrophy. Corticopontine and corticospinal projection fibers are frequently involved.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ctx" document-type="chapter">Cerebrotendinous xanthomatosis</related-object> is characterized by infantile-onset diarrhea, childhood-onset cataract, adolescent- to young adult-onset tendon xanthomas, and adult-onset progressive neurologic dysfunction with dementia, psychiatric disturbances, pyramidal and/or cerebellar signs, dystonia, atypical parkinsonism, peripheral neuropathy, and seizures. The most important and earliest MRI abnormalities are signal abnormalities in the dentate nucleus and cerebellar hemispheric white matter. Additionally, signal abnormalities are often present in the corticospinal tracts and medial lemniscus in the brain stem, and slight signal changes are often seen in the periventricular cerebral white matter.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="lbsl" document-type="chapter">Leukoencephalopathy with brain stem and spinal cord abnormalities and lactate elevation</related-object> (LBSL) is characterized by slowly progressive cerebellar ataxia and spasticity with dorsal column dysfunction. Deterioration of motor skills usually starts in childhood or adolescence, but occasionally not until adulthood. MRI invariably shows spinal cord signal abnormalities over its entire length. Brain stem signal abnormalities are more variable and rarely involve the middle cerebellar peduncles and cerebral peduncles.</p>
          </list-item>
        </list>
        <p>All disorders mentioned can be differentiated by the MRI findings mentioned and the diagnosis can be confirmed by appropriate biochemical and/or genetic testing.</p>
        <p>See also <related-object link-type="booklink" source-id="gene" document-id="leukodys-ov" document-type="chapter">Leukodystrophy Overview</related-object>, which should cover all or most of the differential diagnosis information for this disorder.</p>
      </sec>
      <sec id="cc2-leuk.Management">
        <title>Management</title>
        <sec id="cc2-leuk.Evaluations_Following_Initial_D">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">CLCN2</italic>-related leukoencephalopathy (CC2L), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic examination</p>
            </list-item>
            <list-item>
              <p>Brain MRI if not performed at the time of diagnostic work up</p>
            </list-item>
            <list-item>
              <p>Physical therapy/occupational therapy assessment, if significant neurologic problems are present</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination with attention to visual acuity and visual fields</p>
            </list-item>
            <list-item>
              <p>Audiologic examination</p>
            </list-item>
            <list-item>
              <p>For adult males: evaluation of testicular function</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="cc2-leuk.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Supportive therapy includes the following as needed:</p>
          <list list-type="bullet">
            <list-item>
              <p>Physical therapy and rehabilitation to improve motor function</p>
            </list-item>
            <list-item>
              <p>Special education</p>
            </list-item>
            <list-item>
              <p>Treatment of headache</p>
            </list-item>
            <list-item>
              <p>Guidance for visual impairment</p>
            </list-item>
            <list-item>
              <p>For males with infertility: consultation with a male infertility specialist</p>
            </list-item>
          </list>
        </sec>
        <sec id="cc2-leuk.Surveillance">
          <title>Surveillance</title>
          <p>Annual evaluations including:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic examination</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination</p>
            </list-item>
            <list-item>
              <p>Audiologic assessment</p>
            </list-item>
          </list>
          <p>MRI follow up can be performed once every few years, in the event that the neurologic manifestations change.</p>
        </sec>
        <sec id="cc2-leuk.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Using the <italic toggle="yes">CLCN2</italic> pathogenic variants identified in the proband, it is appropriate to evaluate the older and younger sibs of a proband in order to identify those who would benefit from early diagnosis and routine surveillance for motor, cognitive, vision, and hearing impairment.</p>
          <p>See <xref ref-type="sec" rid="cc2-leuk.Related_Genetic_Counseling_Issu">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="cc2-leuk.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>No pregnancy complications have been identified in affected women to date [Author, personal observation].</p>
        </sec>
        <sec id="cc2-leuk.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="cc2-leuk.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cc2-leuk.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">CLCN2</italic>-related leukoencephalopathy (CC2L) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="cc2-leuk.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">CLCN2</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Offspring will inherit a <italic toggle="yes">CLCN2</italic> pathogenic variant from a parent with CC2L.</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">CLCN2</italic> pathogenic variant.</p>
        </sec>
        <sec id="cc2-leuk.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">CLCN2</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="cc2-leuk.Related_Genetic_Counseling_Issu">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="cc2-leuk.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="cc2-leuk.Prenatal_Testing_and_Preimplant">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">CLCN2</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for CC2L are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="cc2-leuk.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cc2-leuk.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">CLCN2</italic> comprises 15,467 base pairs. The longest transcript variant, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004366.5">NM_004366.5</ext-link>, has 24 exons. The gene has been reported to encode ten transcript variants, four of which are protein-coding. For details on gene and transcripts, see <related-object source-id="gene" document-id="cc2-leuk" object-id="cc2-leuk.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> To date 18 pathogenic variants have been identified in 15 probands.</p>
        <p>Six variants are located in exon 14 and two in exon 11; the remaining are distributed throughout the gene.</p>
        <p>With the small number of known affected individuals to date, no information is available on prevalence in specific ethnic groups.</p>
        <table-wrap id="cc2-leuk.T.clcn2_variants_known_to_the_a" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p><italic toggle="yes">CLCN2</italic> Variants Known to the Authors</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant<break/>Classification</th>
                <th id="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference<break/>Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_1" rowspan="20" valign="middle" align="left" scope="row" colspan="1">
                  <bold>Uncertain</bold>
                  <break/>
                  <bold>significance&#x000a0;<sup>1</sup></bold>
                </td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.130G&#x0003e;A&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly44Arg</td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_4" rowspan="39" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004366.5">NM_004366.5</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_004357.3">NP_004357.3</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.143C&#x0003e;G&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Pro48Arg&#x000a0;<sup>4</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.203G&#x0003e;A&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg68His&#x000a0;<sup>4</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.218G&#x0003e;A&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg73His</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.246C&#x0003e;G&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Phe82Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="col" rowspan="1">c.221-14_221-4del11&#x000a0;<sup>5</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.596G&#x0003e;C&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly199Ala&#x000a0;<sup>4</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.704G&#x0003e;A&#x000a0;<sup>6</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg235Gln&#x000a0;<sup>4</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1730G&#x0003e;A&#x000a0;<sup>6</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg577Gln&#x000a0;<sup>4</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1856&#x02013;3C&#x0003e;T&#x000a0;<sup>7</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.0?&#x000a0;<sup>8</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1930C&#x0003e;T&#x000a0;<sup>6</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg644Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1937G&#x0003e;A&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg646Gln&#x000a0;<sup>4</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2003C&#x0003e;G&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Thr668Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2063G&#x0003e;A&#x000a0;<sup>2,&#x000a0;7,&#x000a0;9</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg688Gly</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c. 2144G&#x0003e;A</td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly715Glu</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2154G&#x0003e;C&#x000a0;<sup>7,&#x000a0;9</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu718Asp</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2173C&#x0003e;T&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg725Trp&#x000a0;<sup>4</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2240G&#x0003e;A&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg747His&#x000a0;<sup>4</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2273G&#x0003e;A&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ser758Asn</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2279C&#x0003e;T&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ala760Val</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Possibly</bold>
                  <break/>
                  <bold>pathogenic</bold>
                </td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.597dup&#x000a0;<sup>5</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Met200AspfsTer32</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_1" rowspan="18" valign="middle" align="left" scope="row" colspan="1">
                  <bold>Pathogenic</bold>
                </td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.64-1107_639del&#x000a0;<sup>10</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Met22LeufsTer5</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.292G&#x0003e;C&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly98Arg&#x000a0;<sup>11</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.430_435del&#x000a0;<sup>10</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu144_Ile145del</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.828dupG&#x000a0;<sup>10</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg277AlafsTer23</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.925C&#x0003e;T&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg309Ter&#x000a0;<sup>11</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1015G&#x0003e;C&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Val339Leu&#x000a0;<sup>11</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1113delinsACTGCTCAT&#x000a0;<sup>12</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ser375CysfsTer6</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1143delT&#x000a0;<sup>10</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly382AlafsTer34</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1304delT&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu435ArgfsTer7&#x000a0;<sup>11</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1397G&#x0003e;A&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly466Glu&#x000a0;<sup>11</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1412G&#x0003e;A&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg471His&#x000a0;<sup>11</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1422_1423delTG&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu475LysfsTer79&#x000a0;<sup>11</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1499C&#x0003e;T&#x000a0;<sup>10</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ala500Val</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1507G&#x0003e;A&#x000a0;<sup>13</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly503Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1709G&#x0003e;A&#x000a0;<sup>2,&#x000a0;10</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Trp570Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1795G&#x0003e;A&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asp599Asn&#x000a0;<sup>11</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1957A&#x0003e;T&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg653Ter&#x000a0;<sup>11</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2386C&#x0003e;T&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gln796Ter&#x000a0;<sup>11</sup></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="cc2-leuk.TF.2.1">
              <label>1. </label>
              <p>Variants reported here were identified in the heterozygous state in patients with epilepsy and/or control individuals.</p>
            </fn>
            <fn id="cc2-leuk.TF.2.2">
              <label>2. </label>
              <p>
                <xref ref-type="bibr" rid="cc2-leuk.REF.klassen.2011.1036">Klassen et al [2011]</xref>
              </p>
            </fn>
            <fn id="cc2-leuk.TF.2.3">
              <label>3. </label>
              <p>
                <xref ref-type="bibr" rid="cc2-leuk.REF.paul.2007.441">Paul et al [2007]</xref>
              </p>
            </fn>
            <fn id="cc2-leuk.TF.2.4">
              <label>4. </label>
              <p>These variants were shown to have a functional impact on CLC-2 function but the pathogenicity of these variants for CC2L in the homozygous state remains unproven.</p>
            </fn>
            <fn id="cc2-leuk.TF.2.5">
              <label>5. </label>
              <p>
                <xref ref-type="bibr" rid="cc2-leuk.REF.haug.2003.527">Haug et al [2003]</xref>
              </p>
            </fn>
            <fn id="cc2-leuk.TF.2.6">
              <label>6. </label>
              <p>
                <xref ref-type="bibr" rid="cc2-leuk.REF.saintmartin.2009.397">Saint-Martin et al [2009]</xref>
              </p>
            </fn>
            <fn id="cc2-leuk.TF.2.7">
              <label>7. </label>
              <p>
                <xref ref-type="bibr" rid="cc2-leuk.REF.d_agostino.2004.1500">D&#x02019;Agostino et al [2004]</xref>
              </p>
            </fn>
            <fn id="cc2-leuk.TF.2.8">
              <label>8. </label>
              <p>Effect on protein unknown</p>
            </fn>
            <fn id="cc2-leuk.TF.2.9">
              <label>9. </label>
              <p>
                <xref ref-type="bibr" rid="cc2-leuk.REF.stogmann.2006.265">Stogmann et al [2006]</xref>
              </p>
            </fn>
            <fn id="cc2-leuk.TF.2.10">
              <label>10. </label>
              <p>
                <xref ref-type="bibr" rid="cc2-leuk.REF.depienne.2013.659">Depienne et al [2013]</xref>
              </p>
            </fn>
            <fn id="cc2-leuk.TF.2.11">
              <label>11. </label>
              <p>Author, unpublished data</p>
            </fn>
            <fn id="cc2-leuk.TF.2.12">
              <label>12. </label>
              <p>
                <xref ref-type="bibr" rid="cc2-leuk.REF.hanagasi.2015.544">Hanagasi et al [2015]</xref>
              </p>
            </fn>
            <fn id="cc2-leuk.TF.2.13">
              <label>13. </label>
              <p>
                <xref ref-type="bibr" rid="cc2-leuk.REF.di_bella.2014.1217">Di Bella et al [2014]</xref>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The start of the open reading frame in exon 1 is utilized in all four transcript variants. The longest protein-coding transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004366.5">NM_004366.5</ext-link> expresses a protein encompassing 898 amino acids. This protein has 12 transmembrane domains and two intracellular CBS domains, and constitutes a voltage-gated chloride channel present at the plasma membrane.</p>
        <p><bold>Abnormal gene product.</bold> All pathogenic variants identi&#x0fb01;ed to date have been shown or suggested to result in either complete or partial loss of function of the protein chloride channel-2 by different mechanisms [<xref ref-type="bibr" rid="cc2-leuk.REF.depienne.2013.659">Depienne at al 2013</xref>]. Overexpression studies have shown that the proteins with the variant p.Leu144_Ile145del, p.Ala500Val, or p.Trp570Ter are retained in the endoplasmic reticulum and are not transported to the plasma membrane. Pathogenic variants introducing a premature termination codon probably lead to mRNA degradation by nonsense-mediated decay [<xref ref-type="bibr" rid="cc2-leuk.REF.depienne.2013.659">Depienne et al 2013</xref>]. Not all variants have, however, been tested [<xref ref-type="bibr" rid="cc2-leuk.REF.di_bella.2014.1217">Di Bella et al 2014</xref>; <xref ref-type="table" rid="cc2-leuk.T.clcn2_variants_known_to_the_a">Table 2</xref>, footnote 11].</p>
        <p><bold>Mouse model.</bold>
<italic toggle="yes">Clcn2</italic>-mutant and <italic toggle="yes">Clcn2</italic>-knockout mice have been studied since 2001 [<xref ref-type="bibr" rid="cc2-leuk.REF.b_sl.2001.1289">B&#x000f6;sl et al 2001</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.blanz.2007.6581">Blanz et al 2007</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.edwards.2010.3264">Edwards et al 2010</xref>]. The phenotype is dominated by visual impairment due to retinopathy and male infertility due to testicular degeneration resulting in azoospermia. A leukoencephalopathy characterized by intramyelinic edema was observed when investigating the brain, but was not clinically apparent [<xref ref-type="bibr" rid="cc2-leuk.REF.blanz.2007.6581">Blanz et al 2007</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.edwards.2010.3264">Edwards et al 2010</xref>]. The mutant mice had no other disease signs and had a normal life span [<xref ref-type="bibr" rid="cc2-leuk.REF.b_sl.2001.1289">B&#x000f6;sl et al 2001</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.blanz.2007.6581">Blanz et al 2007</xref>, <xref ref-type="bibr" rid="cc2-leuk.REF.edwards.2010.3264">Edwards et al 2010</xref>].</p>
      </sec>
      <sec id="cc2-leuk.References">
        <title>References</title>
        <sec id="cc2-leuk.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="cc2-leuk.Literature_Cited.reflist0">
            <ref id="cc2-leuk.REF.blanz.2007.6581">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blanz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweizer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auberson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maier</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muenscher</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000fc;bner</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                </person-group>
                <article-title>Leukoencephalopathy upon disruption of the chloride channel ClC-2.</article-title>
                <source>J Neurosci.</source>
                <year>2007</year>
                <volume>27</volume>
                <fpage>6581</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17567819</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.b_sl.2001.1289">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>B&#x000f6;sl</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000fc;bner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zdebik</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordt</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukhopadhyay</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidoff</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holstein</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                </person-group>
                <article-title>Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl(-) channel disruption.</article-title>
                <source>EMBO J.</source>
                <year>2001</year>
                <volume>20</volume>
                <fpage>1289</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">11250895</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.combi.2009.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Combi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grioni</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Contri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redaelli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redaelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bassi</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barisani</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lavitrano</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tredici</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenchini</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertolini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalpr&#x000e0;</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and genetic familial study of a large cohort of Italian children with idiopathic epilepsy.</article-title>
                <source>Brain Res Bull.</source>
                <year>2009</year>
                <volume>79</volume>
                <fpage>89</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">19200853</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.d_agostino.2004.1500">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>D&#x02019;Agostino</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cecchin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albiero</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garofalo</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambardella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St Hilaire</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwiecinski</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pandolfo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Mutations and polymorphisms of the CLCN2 gene in idiopathic epilepsy.</article-title>
                <source>Neurology.</source>
                <year>2004</year>
                <volume>63</volume>
                <fpage>1500</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15505175</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.depienne.2013.659">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bugiani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupuits</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galanaud</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touitou</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Postma</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Berkel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tollard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darios</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Die-Smulders</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vles</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yalcinkaya</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frints</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalscheuer</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klooster</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamermans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbink</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <article-title>Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study.</article-title>
                <source>Lancet Neurol.</source>
                <year>2013</year>
                <volume>12</volume>
                <fpage>659</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">23707145</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.di_bella.2014.1217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Bella</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pareyson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savoiardo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldarazzo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sagnelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nava</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tedeschi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taroni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salsano</surname>
                    <given-names>E.</given-names>
                  </name>
                </person-group>
                <article-title>Subclinical leukodystrophy and infertility in a man with a novel homozygous CLCN2 mutation.</article-title>
                <source>Neurology.</source>
                <year>2014</year>
                <volume>83</volume>
                <fpage>1217</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25128180</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.edwards.2010.3264">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Edwards</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marin de Evsikova</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gifford</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hicks</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whiting</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varvel</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maphis</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamb</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naggert</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishina</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peachey</surname>
                    <given-names>NS</given-names>
                  </name>
                </person-group>
                <article-title>Photoreceptor degeneration, azoospermia, leukoencephalopathy, and abnormal RPE cell function in mice expressing an early stop mutation in CLCN2.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <year>2010</year>
                <volume>51</volume>
                <fpage>3264</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">20071672</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.everett.2007.145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Everett</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chioza</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aicardi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aschauer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brouwer</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callenbach</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Covanis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dooley</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dulac</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eeg-Olofsson</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feucht</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heils</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kjeldsen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabbout</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sander</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirrell</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKeigue</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taske</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardiner</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Linkage and mutational analysis of CLCN2 in childhood absence epilepsy.</article-title>
                <source>Epilepsy Res.</source>
                <year>2007</year>
                <volume>75</volume>
                <fpage>145</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">17580110</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.hanagasi.2015.544">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanagasi</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bilgi&#x000e7;</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbink</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanagasi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>T&#x000fc;fek&#x000e7;io&#x0011f;lu</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000fc;rvit</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ba&#x0015f;ak</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emre</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Secondary paroxysmal kinesigenic dyskinesia associated with CLCN2 gene mutation.</article-title>
                <source>Parkinsonism Relat Disord.</source>
                <year>2015</year>
                <volume>21</volume>
                <fpage>544</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">25745790</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.haug.2003.527">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haug</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warnstedt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alekov</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sander</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ram&#x000ed;rez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maljevic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hebeisen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubisch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rebstock</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dullinger</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rau</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haverkamp</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beyenburg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giese</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-Newen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Propping</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elger</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahlke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heils</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies.</article-title>
                <source>Nat Genet.</source>
                <year>2003</year>
                <volume>33</volume>
                <fpage>527</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">12612585</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.haug.2009.1043">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haug</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warnstedt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alekov</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sander</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ram&#x000ed;rez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maljevic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hebeisen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubisch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rebstock</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dullinger</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rau</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haverkamp</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beyenburg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giese</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-Newen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Propping</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elger</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahlke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Retraction: Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies.</article-title>
                <source>Nat Genet.</source>
                <year>2009</year>
                <volume>41</volume>
                <fpage>1043</fpage>
                <pub-id pub-id-type="pmid">19710717</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.klassen.2011.1036">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klassen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgess</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheeler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McPherson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourquin</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villasana</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muzny</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noebels</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy.</article-title>
                <source>Cell.</source>
                <year>2011</year>
                <volume>145</volume>
                <fpage>1036</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">21703448</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.kleefusslie.2009.954">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kleefuss-Lie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedl</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cichon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haug</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warnstedt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alekov</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sander</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramirez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maljevic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hebeisen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubisch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rebstock</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dullinger</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rau</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haverkamp</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beyenburg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giese</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-Newen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Propping</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elger</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahlke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>CLCN2 variants in idiopathic generalized epilepsy.</article-title>
                <source>Nat Genet.</source>
                <year>2009</year>
                <volume>41</volume>
                <fpage>954</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19710712</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.niemeyer.2010.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Niemeyer</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cid</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sep&#x000fa;lveda</surname>
                    <given-names>FV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auberson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                </person-group>
                <article-title>No evidence for a role of CLCN2 variants in idiopathic generalized epilepsy.</article-title>
                <source>Nat Genet.</source>
                <year>2010</year>
                <volume>42</volume>
                <fpage>3</fpage>
                <pub-id pub-id-type="pmid">20037607</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.paul.2007.441">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paul</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeyaraj</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huber</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seebohm</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;hmer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremsner</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kun</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <article-title>Alterations in the cytoplasmic domain of CLCN2 result in altered gating kinetics.</article-title>
                <source>Cell Physiol Biochem.</source>
                <year>2007</year>
                <volume>20</volume>
                <fpage>441</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">17762171</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.planellscases.2009">
              <mixed-citation publication-type="other">Planells-Cases R, Jentsch TJ. Chloride channelopathies. Biochim Biophys Acta. 2009;1792:173-89.</mixed-citation>
            </ref>
            <ref id="cc2-leuk.REF.saintmartin.2009.397">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saint-Martin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gauvain</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teodorescu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gourfinkel-An</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fedirko</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>YG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maljevic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ernst</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Olivares</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahlke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabbout</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poncer</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Two novel CLCN2 mutations accelerating chloride channel deactivation are associated with idiopathic generalized epilepsy.</article-title>
                <source>Hum Mutat.</source>
                <year>2009</year>
                <volume>30</volume>
                <fpage>397</fpage>
                <lpage>405</lpage>
                <pub-id pub-id-type="pmid">19191339</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.schiffmann.2009.750">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <article-title>Invited article: an MRI-based approach to the diagnosis of white matter disorders.</article-title>
                <source>Neurology.</source>
                <year>2009</year>
                <volume>72</volume>
                <fpage>750</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19237705</pub-id>
              </element-citation>
            </ref>
            <ref id="cc2-leuk.REF.stogmann.2006.265">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stogmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichtner</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmied</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hotzy</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asmus</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leutmezer</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonelli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assem-Hilger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vass</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatala</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meitinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the <italic toggle="yes">CLCN2</italic> gene are a rare cause of idiopathic generalized epilepsy syndromes.</article-title>
                <source>Neurogenetics.</source>
                <year>2006</year>
                <volume>7</volume>
                <fpage>265</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16932951</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cc2-leuk.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cc2-leuk.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>5 November 2015 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>22 April 2015 (mvdk) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="cc2-leuk.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>MRI of an individual age 50 years with CC2L. Note the T<sub>2</sub>-weighted signal abnormalities (a-d) in the middle cerebellar peduncles (blue arrow in a), cerebral peduncles (green arrow in b), and posterior limb of the internal capsule (red arrow in d). All cerebral white matter except for the directly subcortical white matter has a slightly abnormal signal (yellow arrow in c). The diffusion-weighted image (e) and apparent diffusion coefficient map (f) show diffusion restriction in the posterior limb of the internal capsule (red arrows).</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cc2-leuk-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
